2016
DOI: 10.1177/0145482x1611000304
|View full text |Cite
|
Sign up to set email alerts
|

Miami Lighthouse for the Blind and Visually Impaired Case Study: Vision Rehabilitation for the First Florida Resident to Receive the Argus II “Bionic Eye”

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 1 publication
0
5
0
Order By: Relevance
“…Currently, patients are trained to suppress eye movements at all times in order to maintain alignment between the camera and pupillary axes 14 , 15 but the accessibility of this technique is questionable. Patients have little intuition of the orientation of their eyes 8 and have difficulty suppressing eye movements, particularly those associated with nystagmus.…”
Section: Introductionmentioning
confidence: 99%
“…Currently, patients are trained to suppress eye movements at all times in order to maintain alignment between the camera and pupillary axes 14 , 15 but the accessibility of this technique is questionable. Patients have little intuition of the orientation of their eyes 8 and have difficulty suppressing eye movements, particularly those associated with nystagmus.…”
Section: Introductionmentioning
confidence: 99%
“…This is known to cause a dissociation between the camera and pupillary axes in implanted patients [4,[22][23][24]. Patients are thus implicitly trained to maintain a stationary forward-facing eye gaze [25] to prevent misalignment between the pupillary and camera axes. Given such interventions, the eyegaze movement is not taken into account when encoding the captured image via the prosthesis.…”
Section: Background and Related Work 21 External Image Capture And Eg...mentioning
confidence: 99%
“…21 In November 2014, a legally blind female patient, who became blind at the age of 42 owing to RP, became the first person in the USA to receive the Argus II bionic device. 22 Approximately one-third of the subjects experienced measurable improvements in visual acuity. 21 The Alpha-IMS has been tested in nine subjects to date and has received regulatory approval in Europe, 23 improved light location detection over a 12-month period.…”
Section: Clinical Trialsmentioning
confidence: 99%